Wixela Inhub
(fluticasone propionate and salmeterol inhalation powder, USP)

the first FDA-approved generic version of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder).

Watch the step-by-step video >>

INTRODUCING

Wixela Inhub

Wixela Inhub is a new generic dry powder inhaler that contains the same active ingredients as ADVAIR DISKUS that have been shown to provide appropriate patients control of their asthma symptoms and improve lung function for patients with COPD.

Watch the step-by-step video below to learn how to use the Wixela Inhub.

How To Use

Download a PDF with step by step instructions for administering Wixela Inhub

How-To-Use Guide

Patient Brochure

Download the Wixela Inhub patient brochure and discuss with your doctor or pharmacist at your next visit

View the brochure

Available Strengths

Same 3 Dosage Strengths as ADVAIR DISKUS

Your doctor will choose the dose of Wixela Inhub that is right for you. Only the 250/50 mcg strength is indicated for COPD.

Wixela Inhub 100/50 mcg
(fluticasone propionate and salmeterol inhalation powder, USP)
Wixela Inhub 250/50 mcg
(fluticasone propionate and salmeterol inhalation powder, USP)
Wixela Inhub 500/50 mcg
(fluticasone propionate and salmeterol inhalation powder, USP)

Device Features

Designed to Help Enable a Seamless Transition

When you receive Wixela Inhub at the pharmacy, you may notice that the device looks different from your current inhaler. Wixela Inhub contains the same medication as ADVAIR DISKUS, with similar steps for use.

How To Use

Your Wixela Inhub

Wixela Inhub was designed with patients in mind to help you make a seamless transition from ADVAIR DISKUS. The steps for using Wixela Inhub are similar to those for ADVAIR DISKUS:


† Hold Wixela InHub in the vertical position when inhaling.



SAVINGS OFFER

Pay as little as $10* on each prescription or refill of Wixela Inhub

Patients may be eligible* to receive up to $50 off of their out-of-pocket expenses after they pay the first $10 per 30-day prescription of Wixela Inhub. The Wixela Inhub Savings Card is valid for use up to 12 times per calendar year, with each 30-day prescription counting as one use, for a total benefit of up to $600 per calendar year. Patients can print the savings offer from their computer or store it on their smartphone and present it to their pharmacist.

Register Today >>

*Eligibility restrictions apply. For full terms and conditions, visit www.wixela.com/copay. This offer is not valid for patients covered by any state or federally funded healthcare program, including Medicare (Part D or otherwise), Medicaid, Medigap, VA, DoD or TriCare. This offer is void where prohibited or restricted by law. Mylan Pharmaceuticals reserves the right to amend or end this program at any time without notice.

x

Thank you for signing up

IMPORTANT SAFETY INFORMATION

  • WIXELA INHUB contains salmeterol, the same medicine found in SEREVENT® (salmeterol xinafoate inhalation powder). LABA medicines such as salmeterol when used alone increase the risk of hospitalizations and death from asthma problems. WIXELA INHUB contains an ICS and a LABA. When an ICS and LABA are used together, there is not a significant increased risk in hospitalizations and death from asthma problems.
  • Do not use WIXELA INHUB to treat sudden breathing problems from asthma or COPD. Always have a rescue inhaler with you to treat sudden symptoms.
  • Do not use WIXELA INHUB if you have a severe allergy to milk proteins. Do not use WIXELA INHUB if you are allergic to any of the ingredients in the products. Ask your healthcare provider if you are not sure.
  • Do not use WIXELA INHUB more often than prescribed.
  • Do not take WIXELA INHUB with other medicines that contain a LABA for any reason.
  • Tell your healthcare provider about all the medicines you take and about all of your health conditions.
  • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms, or if your peak flow meter results decrease. Your healthcare provider will tell you the numbers that are right for you.
  • WIXELA INHUB can cause serious side effects, including:
    • Fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using WIXELA INHUB to help reduce your chance of getting thrush.
    • Pneumonia. People with COPD have a higher chance of getting pneumonia. WIXELA INHUB may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: increase in mucus (sputum) production; change in mucus color; fever; chills; increased cough; increased breathing problems.
    • Weakened immune system and increased chance of getting infections (immunosuppression). You should avoid exposure to chickenpox and measles, and, if exposed, tell your healthcare provider right away. Worsening of existing tuberculosis, fungal, bacterial, viral, or parasitic infections, or herpes infection of the eye (ocular herpes simplex) may occur.
    • Reduced adrenal function. This can happen when you stop taking an oral corticosteroid (such as prednisone) and start taking a medicine containing an inhaled corticosteroid (such as WIXELA INHUB). During this transition period, when your body is under stress such as from fever, trauma (such as a car accident), infection, surgery, or worse COPD symptoms, adrenal insufficiency can get worse and may cause death. Symptoms of adrenal insufficiency include: feeling tired; lack of energy; weakness; nausea and vomiting; low blood pressure (hypotension).
    • Sudden breathing problems immediately after inhaling your medicine. If you have sudden breathing problems immediately after inhaling your medicine, stop using WIXELA INHUB and call your healthcare provider right away.
    • Serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction: rash; hives; swelling of your face, mouth, and tongue; breathing problems.
    • Effects on heart: increased blood pressure; a fast or irregular heartbeat; chest pain.
    • Effects on nervous system: tremor; nervousness.
    • Bone thinning or weakness (osteoporosis).
    • Slowed growth in children. A child's growth should be checked regularly by the healthcare provider.
    • Eye problems including glaucoma, increased pressure in your eye, cataracts, or other changes in vision. You should have regular eye exams while using WIXELA INHUB.
    • Changes in laboratory blood values (sugar, potassium, certain types of white blood cells).
  • Common side effects of WIXELA INHUB for asthma include upper respiratory tract infection, throat irritation, hoarseness and voice changes, thrush in your mouth or throat, bronchitis, cough, headache, and nausea and vomiting. In children with asthma, infections in the ear, nose, and throat are common.
  • Common side effects of WIXELA INHUB for COPD include thrush in your mouth or throat, throat irritation, hoarseness and voice changes, viral respiratory infections, headache, and muscle and bone pain.

Indications

WIXELA INHUB is a twice-daily prescription medicine used to control symptoms of asthma and to prevent symptoms such as wheezing in patients 4 years and older.  WIXELA INHUB is for adults and children with asthma who are not well controlled with an asthma control medicine, such as an inhaled corticosteroid (ICS) medicine and need both an ICS and long-acting beta2-adrenergic agonist (LABA) medicine.

WIXELA INHUB 250/50 is a twice-daily prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and fewer flare-ups.

WIXELA INHUB is not used to relieve sudden breathing problems from asthma or COPD and won't replace a rescue inhaler.

 

Please see accompanying full Prescribing Information and Patient Information.

For additional information please contact us at 800-395-3376.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

IMPORTANT SAFETY INFORMATION

  • WIXELA INHUB contains salmeterol, the same medicine found in SEREVENT® (salmeterol xinafoate inhalation powder). LABA medicines such as salmeterol when used alone increase the risk of hospitalizations and death from asthma problems. WIXELA INHUB contains an ICS and a LABA. When an ICS and LABA are used together, there is not a significant increased risk in hospitalizations and death from asthma problems.
  • Do not use WIXELA INHUB to treat sudden breathing problems from asthma or COPD. Always have a rescue inhaler with you to treat sudden symptoms.
  • Do not use WIXELA INHUB if you have a severe allergy to milk proteins. Do not use WIXELA INHUB if you are allergic to any of the ingredients in the products. Ask your healthcare provider if you are not sure.
  • Do not use WIXELA INHUB more often than prescribed.
  • Do not take WIXELA INHUB with other medicines that contain a LABA for any reason.
  • Tell your healthcare provider about all the medicines you take and about all of your health conditions.
  • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms, or if your peak flow meter results decrease. Your healthcare provider will tell you the numbers that are right for you.
  • WIXELA INHUB can cause serious side effects, including:
    • Fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using WIXELA INHUB to help reduce your chance of getting thrush.
    • Pneumonia. People with COPD have a higher chance of getting pneumonia. WIXELA INHUB may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: increase in mucus (sputum) production; change in mucus color; fever; chills; increased cough; increased breathing problems.
    • Weakened immune system and increased chance of getting infections (immunosuppression). You should avoid exposure to chickenpox and measles, and, if exposed, tell your healthcare provider right away. Worsening of existing tuberculosis, fungal, bacterial, viral, or parasitic infections, or herpes infection of the eye (ocular herpes simplex) may occur.
    • Reduced adrenal function. This can happen when you stop taking an oral corticosteroid (such as prednisone) and start taking a medicine containing an inhaled corticosteroid (such as WIXELA INHUB). During this transition period, when your body is under stress such as from fever, trauma (such as a car accident), infection, surgery, or worse COPD symptoms, adrenal insufficiency can get worse and may cause death. Symptoms of adrenal insufficiency include: feeling tired; lack of energy; weakness; nausea and vomiting; low blood pressure (hypotension).
    • Sudden breathing problems immediately after inhaling your medicine. If you have sudden breathing problems immediately after inhaling your medicine, stop using WIXELA INHUB and call your healthcare provider right away.
    • Serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction: rash; hives; swelling of your face, mouth, and tongue; breathing problems.
    • Effects on heart: increased blood pressure; a fast or irregular heartbeat; chest pain.
    • Effects on nervous system: tremor; nervousness.
    • Bone thinning or weakness (osteoporosis).
    • Slowed growth in children. A child's growth should be checked regularly by the healthcare provider.
    • Eye problems including glaucoma, increased pressure in your eye, cataracts, or other changes in vision. You should have regular eye exams while using WIXELA INHUB.
    • Changes in laboratory blood values (sugar, potassium, certain types of white blood cells).
  • Common side effects of WIXELA INHUB for asthma include upper respiratory tract infection, throat irritation, hoarseness and voice changes, thrush in your mouth or throat, bronchitis, cough, headache, and nausea and vomiting. In children with asthma, infections in the ear, nose, and throat are common.
  • Common side effects of WIXELA INHUB for COPD include thrush in your mouth or throat, throat irritation, hoarseness and voice changes, viral respiratory infections, headache, and muscle and bone pain.

Indications

WIXELA INHUB is a twice-daily prescription medicine used to control symptoms of asthma and to prevent symptoms such as wheezing in patients 4 years and older.  WIXELA INHUB is for adults and children with asthma who are not well controlled with an asthma control medicine, such as an inhaled corticosteroid (ICS) medicine and need both an ICS and long-acting beta2-adrenergic agonist (LABA) medicine.

WIXELA INHUB 250/50 is a twice-daily prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and fewer flare-ups.

WIXELA INHUB is not used to relieve sudden breathing problems from asthma or COPD and won't replace a rescue inhaler.

 

Please see accompanying full Prescribing Information and Patient Information.

For additional information please contact us at 800-395-3376.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

You are now leaving wixela.com.

The website you are about to access is not owned or controlled by Mylan Pharmaceuticals.

MYLAN PHARMACEUTICALS ASSUMES NO RESPONSIBILITY FOR, AND MAKES NO REPRESENTATION AS TO THE ACCURACY OF, ANY CONTENT CONTAINED ON THE WEBSITE YOU ARE ABOUT TO ACCESS.